Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114909) titled 'Scientific title Safety and Efficacy of Intranasal Atomized Esketamine in the Perioperative Period of Thoracoscopic and Laparoscopic Esophagectomy for Esophageal Cancer: A Randomized, Double-Blind Clinical Study' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Anhui Provincial Cancer Hospital
Condition:
esophageal cancer
Intervention:
Physiological saline control group (CON group):Intranasal atomization of normal saline
0.5 mg/kg Esketamine group (E1 group):Intervention Intranasal atomization of 0.5mg/kg esketamine + normal saline
Recruitment Status: Not Recruiti...